Lorazepam linked to shorter progression-free survival in pancreatic cancer patients

[News]

Patients with pancreatic cancer who took the benzodiazepine lorazepam (Ativan), commonly prescribed to treat anxiety during cancer treatment, had a shorter progression-free survival than patients who did not, according to results published in Clinical Cancer Research, a journal of the American Association for Cancer Research (AACR).

More... (https://www.news-medical.net/news/20230817/Lorazepam-linked-to-shorter-progression-free-survival-in-pancreatic-cancer-patients.aspx)